Mictonorm

Propiverine Hydrochloride, the active ingredient in Mictonorm, is an antimuscarinic presented as an oral dosage form for oral use. It is indicated for the management of overactive bladder symptoms such as urgency, frequency and urge incontinence in adult patients. GNH USA supplies Mictonorm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mictonorm is an antimuscarinic medication used to treat disorders of bladder storage function. - Overactive bladder: reduces involuntary detrusor contractions and improves bladder capacity. - Urinary urgency: lessens the sudden, compelling need to void. - Urinary frequency: decreases the number of daily voids. - Urge urinary incontinence: helps prevent involuntary leakage associated with urgency.

Propiverine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dry mouth: reduced salivary secretion leading to a feeling of thirst. - Constipation: slowed gastrointestinal motility. - Blurred vision: transient changes in visual acuity. - Headache: mild to moderate head discomfort.

Serious or Rare Side Effects: - Urinary retention: difficulty initiating or maintaining urine flow. - Cardiac arrhythmia: irregular heart rhythm that may require medical evaluation.

Before initiating therapy, clinicians should consider several safety factors. - Renal function assessment: adjust use in patients with impaired clearance. - Anticholinergic burden: evaluate concomitant drugs with similar effects. - Urinary retention history: avoid in patients with known obstruction. - Elderly patients: monitor closely for cognitive changes and falls. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Propiverine can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may raise propiverine levels. - Potent anticholinergic agents (e.g., trihexyphenidyl): additive anticholinergic effects.

Moderate Interactions (Monitor Closely): - Diuretics: may exacerbate urinary frequency changes. - Beta‑3 agonists (e.g., mirabegron): potential for reduced bladder‑relaxant effect. - Other antimuscarinics: increased risk of anticholinergic side effects.